Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and allylamine

23-seleno-25-homotaurocholic acid has been researched along with allylamine in 1 studies

Compound Research Comparison

Studies
(23-seleno-25-homotaurocholic acid)
Trials
(23-seleno-25-homotaurocholic acid)
Recent Studies (post-2010)
(23-seleno-25-homotaurocholic acid)
Studies
(allylamine)
Trials
(allylamine)
Recent Studies (post-2010) (allylamine)
147842734112217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johns, W; Lal, S; Leitao, E; McLaughlin, J; Orekoya, O; Paine, P1

Other Studies

1 other study(ies) available for 23-seleno-25-homotaurocholic acid and allylamine

ArticleYear
Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy.
    Clinical medicine (London, England), 2015, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Colon; Diarrhea; Female; Humans; Male; Middle Aged; Retrospective Studies; Steatorrhea; Taurocholic Acid; Young Adult

2015